Inulin (10 g/L) |
24 h |
Fresh stool samples from 9 healthy humans (ex vivo system) |
Acetate, propionate, and butyrate |
(14) |
FOS (12 g/d)-enriched inulin supplementation |
0, 12, 24, and 48 h |
Fecal cultures from pigs (in vitro fecal fermentation) |
Succinate, lactate, propionate and butyrate |
(16) |
Inulin (24 g) plus glucose (75 g)/water (300 mL) |
0-6 h |
25 adults with BMI of 20-35 kg/m2
|
Propionate and butyrate |
(15) |
Inulin (24 g) plus high-fructose corn syrup (56 g)/drinks (400 mL) |
4-6 h |
12 healthy humans |
Serum acetate, propionate, and butyrate |
(17) |
U-13C-inulin (0.5 g)/inulin (24 g) in a high-fat milkshake |
7 h |
14 healthy, overweight to obese men |
Plasma propionate, butyrate, acetate |
(18) |
Inulin-type fructans |
6 weeks |
25 patients with type 2 diabetes mellitus |
Significantly increased fecal concentrations of total short-chain fatty acids, acetic acid and propionic acid |
(19, 20) |
Water with 20% sucrose and 5% inulin (w/w) |
6 weeks |
Male Sprague–Dawley rats (6 weeks) |
Propionate and butyrate; fecal contents of indole-3-acetic acid and kynurenic acid |
(21) |
Basal diet containing 0.5% inulin |
21 days |
20 growing-pigs |
Acetate and butyrate concentrations in cecum |
(22) |
Control diet with 20% inulin |
3 weeks |
BALB/c mice (6–8 weeks) |
Fecal acetate, propionate and butyrate |
(23) |
High-fat/high-sucrose diet containing inulin (7.5% kcal) |
12 weeks |
Male C57BL/6J mice (8 weeks) |
Acetic acid in jejunum; succinic acid, acetic acid and propionic acid in the rectal feces and portal vein serum |
(24) |